Heterocyclic compound
Provided is a heterocyclic compound that can have an antagonistic action on an NMDA receptor containing the NR2B subunit, and is expected to be useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compou...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Tokunaga, Norihito Matsumoto, Shigemitsu Kamei, Taku Kohara, Yasuhisa Ogino, Masaki Ohashi, Tomoko Ito, Mitsuhiro Kaku, Tomohiro Oguro, Yuya Wakabayashi, Takeshi Kimura, Eiji |
| description | Provided is a heterocyclic compound that can have an antagonistic action on an NMDA receptor containing the NR2B subunit, and is expected to be useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I):wherein each symbol is as described in the DESCRIPTION, or a salt thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11713311B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11713311B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11713311B23</originalsourceid><addsrcrecordid>eNrjZBD1SC1JLcpPrkzOyUxWSM7PLcgvzUvhYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxocGGhuaGxsaGhk5GxsSoAQCRkiF3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Heterocyclic compound</title><source>esp@cenet</source><creator>Tokunaga, Norihito ; Matsumoto, Shigemitsu ; Kamei, Taku ; Kohara, Yasuhisa ; Ogino, Masaki ; Ohashi, Tomoko ; Ito, Mitsuhiro ; Kaku, Tomohiro ; Oguro, Yuya ; Wakabayashi, Takeshi ; Kimura, Eiji</creator><creatorcontrib>Tokunaga, Norihito ; Matsumoto, Shigemitsu ; Kamei, Taku ; Kohara, Yasuhisa ; Ogino, Masaki ; Ohashi, Tomoko ; Ito, Mitsuhiro ; Kaku, Tomohiro ; Oguro, Yuya ; Wakabayashi, Takeshi ; Kimura, Eiji</creatorcontrib><description>Provided is a heterocyclic compound that can have an antagonistic action on an NMDA receptor containing the NR2B subunit, and is expected to be useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I):wherein each symbol is as described in the DESCRIPTION, or a salt thereof.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230801&DB=EPODOC&CC=US&NR=11713311B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230801&DB=EPODOC&CC=US&NR=11713311B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Tokunaga, Norihito</creatorcontrib><creatorcontrib>Matsumoto, Shigemitsu</creatorcontrib><creatorcontrib>Kamei, Taku</creatorcontrib><creatorcontrib>Kohara, Yasuhisa</creatorcontrib><creatorcontrib>Ogino, Masaki</creatorcontrib><creatorcontrib>Ohashi, Tomoko</creatorcontrib><creatorcontrib>Ito, Mitsuhiro</creatorcontrib><creatorcontrib>Kaku, Tomohiro</creatorcontrib><creatorcontrib>Oguro, Yuya</creatorcontrib><creatorcontrib>Wakabayashi, Takeshi</creatorcontrib><creatorcontrib>Kimura, Eiji</creatorcontrib><title>Heterocyclic compound</title><description>Provided is a heterocyclic compound that can have an antagonistic action on an NMDA receptor containing the NR2B subunit, and is expected to be useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I):wherein each symbol is as described in the DESCRIPTION, or a salt thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD1SC1JLcpPrkzOyUxWSM7PLcgvzUvhYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxocGGhuaGxsaGhk5GxsSoAQCRkiF3</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Tokunaga, Norihito</creator><creator>Matsumoto, Shigemitsu</creator><creator>Kamei, Taku</creator><creator>Kohara, Yasuhisa</creator><creator>Ogino, Masaki</creator><creator>Ohashi, Tomoko</creator><creator>Ito, Mitsuhiro</creator><creator>Kaku, Tomohiro</creator><creator>Oguro, Yuya</creator><creator>Wakabayashi, Takeshi</creator><creator>Kimura, Eiji</creator><scope>EVB</scope></search><sort><creationdate>20230801</creationdate><title>Heterocyclic compound</title><author>Tokunaga, Norihito ; Matsumoto, Shigemitsu ; Kamei, Taku ; Kohara, Yasuhisa ; Ogino, Masaki ; Ohashi, Tomoko ; Ito, Mitsuhiro ; Kaku, Tomohiro ; Oguro, Yuya ; Wakabayashi, Takeshi ; Kimura, Eiji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11713311B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Tokunaga, Norihito</creatorcontrib><creatorcontrib>Matsumoto, Shigemitsu</creatorcontrib><creatorcontrib>Kamei, Taku</creatorcontrib><creatorcontrib>Kohara, Yasuhisa</creatorcontrib><creatorcontrib>Ogino, Masaki</creatorcontrib><creatorcontrib>Ohashi, Tomoko</creatorcontrib><creatorcontrib>Ito, Mitsuhiro</creatorcontrib><creatorcontrib>Kaku, Tomohiro</creatorcontrib><creatorcontrib>Oguro, Yuya</creatorcontrib><creatorcontrib>Wakabayashi, Takeshi</creatorcontrib><creatorcontrib>Kimura, Eiji</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Tokunaga, Norihito</au><au>Matsumoto, Shigemitsu</au><au>Kamei, Taku</au><au>Kohara, Yasuhisa</au><au>Ogino, Masaki</au><au>Ohashi, Tomoko</au><au>Ito, Mitsuhiro</au><au>Kaku, Tomohiro</au><au>Oguro, Yuya</au><au>Wakabayashi, Takeshi</au><au>Kimura, Eiji</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Heterocyclic compound</title><date>2023-08-01</date><risdate>2023</risdate><abstract>Provided is a heterocyclic compound that can have an antagonistic action on an NMDA receptor containing the NR2B subunit, and is expected to be useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I):wherein each symbol is as described in the DESCRIPTION, or a salt thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US11713311B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Heterocyclic compound |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T14%3A42%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Tokunaga,%20Norihito&rft.date=2023-08-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11713311B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |